Viewing data from:

KENACORT

NDA

TRIAMCINOLONE DIACETATE | N012515 | DELCOR ASSET CORP

1 strength0 unique patents0 unique exclusivities

PTAB Proceedings

No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board

Patent Reexaminations

No ex parte or inter partes reexamination proceedings found at USPTO

Hatch-Waxman Litigation

No ANDA patent litigation cases (NOS 835) matched from PACER

Citizen Petitions

No FDA citizen petitions matched from Regulations.gov

Clinical Trials

No clinical trials found on ClinicalTrials.gov for this drug

API Supply Chain1 active DMF4 inactive

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

FARMABIOS SPATRIAMCINOLONE DIACETATE

DMF 175612004

ANTIBIOTICOS SPAInactiveTRIAMCINOLONE DIACETATE

DMF 22071973

BLASCHIM SPAInactiveTRIAMCINOLONE DIACETATE

DMF 28511977

DIOSYNTH BVInactiveTRIAMCINOLONE DIACETATE

DMF 42071981

SOCIETA ITALIANA CORTICOSTEROIDI SPAInactiveTRIAMCINOLONE DIACETATE

DMF 47181982

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — EQ 4MG BASE/5ML

0 patents0 exclusivities▴

SYRUP;ORAL | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.